메뉴 건너뛰기




Volumn 97, Issue 7, 2006, Pages 947-951

Frequency of recurrent ST-elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaques

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BIOLOGICAL MARKER; FIBRINOLYTIC AGENT; HEPARIN; HIRULOG; STREPTOKINASE;

EID: 33645095231     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.10.031     Document Type: Article
Times cited : (7)

References (14)
  • 3
    • 0035312553 scopus 로고    scopus 로고
    • Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: An angioscopic study
    • M. Asakura, Y. Ueda, O. Yamaguchi, T. Adachi, A. Hirayama, M. Hori, K. Kodama Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction an angioscopic study J Am Coll Cardiol 37 2002 1284 1288
    • (2002) J Am Coll Cardiol , vol.37 , pp. 1284-1288
    • Asakura, M.1    Ueda, Y.2    Yamaguchi, O.3    Adachi, T.4    Hirayama, A.5    Hori, M.6    Kodama, K.7
  • 4
    • 0037072442 scopus 로고    scopus 로고
    • Plaque vulnerability, plaque rupture, and acute coronary syndromes. (Multi)-focal manifestation of a systemic disease process
    • P. Schoenhagen, E. Tuzcu, S. Ellis Plaque vulnerability, plaque rupture, and acute coronary syndromes. (Multi)-focal manifestation of a systemic disease process Circulation 106 2002 760 762
    • (2002) Circulation , vol.106 , pp. 760-762
    • Schoenhagen, P.1    Tuzcu, E.2    Ellis, S.3
  • 5
    • 0000214772 scopus 로고    scopus 로고
    • Prognostic significance of nonfatal myocardial reinfarction in survivors of a first infarction
    • R. van Domburg, J. Deckers, P. van Bergen, A. Azar, J.J.C. Jonker, M. Simoons Prognostic significance of nonfatal myocardial reinfarction in survivors of a first infarction Neth Heart J 9 2001 166 171
    • (2001) Neth Heart J , vol.9 , pp. 166-171
    • Van Domburg, R.1    Deckers, J.2    Van Bergen, P.3    Azar, A.4    Jonker, J.J.C.5    Simoons, M.6
  • 6
    • 0035845674 scopus 로고    scopus 로고
    • Early reinfarction after fibrinolysis: Experience from the Global Utilization of Streptokinase and Tissue Plasminogen Activator (Alteplase) for Occluded Coronary Arteries (GUSTO I) and Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Trials
    • M.P. Hudson, C.B. Granger, E.J. Topol, K.S. Pieper, P.W. Armstrong, G.I. Barbash, A.D. Guerci, A. Vahanian, R.M. Califf, E.M. Ohman Early reinfarction after fibrinolysis experience from the Global Utilization of Streptokinase and Tissue Plasminogen Activator (Alteplase) for Occluded Coronary Arteries (GUSTO I) and Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Trials Circulation 104 2001 1229 1235
    • (2001) Circulation , vol.104 , pp. 1229-1235
    • Hudson, M.P.1    Granger, C.B.2    Topol, E.J.3    Pieper, K.S.4    Armstrong, P.W.5    Barbash, G.I.6    Guerci, A.D.7    Vahanian, A.8    Califf, R.M.9    Ohman, E.M.10
  • 7
    • 0035651983 scopus 로고    scopus 로고
    • Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: The HERO-2 randomised trial
    • The Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators
    • The Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction the HERO-2 randomised trial Lancet 358 2001 1855 1863
    • (2001) Lancet , vol.358 , pp. 1855-1863
  • 10
    • 0038202918 scopus 로고    scopus 로고
    • The impact of gender on the treatment and outcomes of patients with early reinfarction after fibrinolysis: Insights from ASSENT-2
    • ASSENT-2 Investigators P.W.
    • M.C. Tjandrawidjaja, Y. Fu, S.G. Goodman, F. van de Werf, C. Granger, P.W. Armstrong ASSENT-2 Investigators The impact of gender on the treatment and outcomes of patients with early reinfarction after fibrinolysis insights from ASSENT-2 Eur Heart J 24 2003 1024 1034
    • (2003) Eur Heart J , vol.24 , pp. 1024-1034
    • Tjandrawidjaja, M.C.1    Fu, Y.2    Goodman, S.G.3    Van De Werf, F.4    Granger, C.5    Armstrong6
  • 14
    • 33645051861 scopus 로고    scopus 로고
    • Blinded adjudication of reinfarction following fibrinolysis - Data from the HERO-2 Trial
    • HERO-2 Investigators French J.K.*Edmond J.J.*Aylward P.A.*Wong C.K.*Stewart R.A.H.*Williams B.F.*Gerber I.L.*De Pasquale C.*O'Connell R.*Simes R.J.*White H.D.
    • HERO-2 Investigators J.K. French, J.J. Edmond, P.A. Aylward, C.K. Wong, R.A.H. Stewart, B.F. Williams, I.L. Gerber, C. De Pasquale, R. O'Connell, R.J. Simes, H.D. White Blinded adjudication of reinfarction following fibrinolysis - data from the HERO-2 Trial J Am Coll Cardiol 41 suppl 2003 375A
    • (2003) J Am Coll Cardiol , vol.41 , Issue.SUPPL.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.